Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

COLLEGIUM PHARMACEUTICAL, INC.

(COLL)
Real-time geschatte koers. Geschatte realtime Cboe BZX - 28/10 20:46:31
20.52 USD   -0.92%
06/08COLLEGIUM PHARMACEUTICAL, INC. : Cantor Fitzgerald haalt aandeel van kooplijst
MM
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op COLLEGIUM PHARMACEUTICAL, INC.
21/10COLLEGIUM PHARMACEUTICAL : to Host Conference Call to Discuss Third Quarter 2021 Financial..
30/09COLLEGIUM PHARMACEUTICAL, INC : Change in Directors or Principal Officers, Other Events (f..
30/09Collegium Pharmaceutical, Inc. Announces Executive Changes
13/09Collegium Announces Four Posters Presented at PAINWeek 2021 National Conference
01/09COLLEGIUM PHARMACEUTICAL : to Participate in Upcoming Investor Conferences
16/08Top Midday Gainers
16/08COLLEGIUM PHARMACEUTICAL : Approves $100 Million Share Buyback Program
16/08COLLEGIUM PHARMACEUTICAL : Material Event (Form 8-K)
16/08COLLEGIUM PHARMACEUTICAL, INC : Other Events (form 8-K)
16/08COLLEGIUM PHARMACEUTICAL : Announces $100 Million Share Repurchase Program
16/08Collegium Pharmaceutical, Inc. announces an Equity Buyback for $100 million worth of it..
16/08Collegium Pharmaceutical, Inc. authorizes a Buyback Plan.
06/08COLLEGIUM PHARMACEUTICAL : Posts Higher Q2 Earnings, Product Revenue
05/08COLLEGIUM PHARMACEUTICAL : Q2 Earnings Snapshot
05/08COLLEGIUM PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and..
05/08COLLEGIUM PHARMACEUTICAL, INC : Results of Operations and Financial Condition, Financial S..
05/08Collegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 Million
05/08Collegium Pharmaceutical, Inc. Reports Earnings Results for the Second Quarter Ended Ju..
05/08Collegium Pharmaceutical, Inc. Provides Revenue Guidance for the Full Year 2021
21/07Collegium to Host Conference Call to Discuss Second Quarter 2021 Financial Results and ..
16/06Collegium Announces Publication of Real-World Data in Journal of Pain Research
03/06INSIDER TRENDS : Collegium Pharmaceutical Insider Exercises Options Derivative Securities,..
02/06COLLEGIUM PHARMACEUTICAL, INC : Regulation FD Disclosure, Financial Statements and Exhibit..
24/05COLLEGIUM PHARMACEUTICAL : Departure of Directors or Certain Officers; Election of Directo..
24/05COLLEGIUM PHARMACEUTICAL, INC : Change in Directors or Principal Officers, Submission of M..
20/05Collegium to Participate in Upcoming Investor Conference
12/05INSIDER TRENDS : Collegium Pharmaceutical Insider Continues 90-Day Selling Trend
06/05COLLEGIUM PHARMACEUTICAL : Q1 Earnings Snapshot
06/05COLLEGIUM PHARMACEUTICAL, INC : Results of Operations and Financial Condition, Change in D..
06/05COLLEGIUM PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and..
06/05Collegium Reports Record Quarterly Revenue of $87.7 Million
06/05Collegium Pharmaceutical, Inc. Reports Earnings Results for the First Quarter Ended Mar..
06/05Collegium Pharmaceutical, Inc. Announces Executive Change, Effective May 24, 2021
06/05Collegium Pharmaceutical, Inc. Announces Appointment of Colleen Tupper as Executive Vic..
15/04Collegium to Host Conference Call to Discuss First Quarter 2021 Financial Results and P..
06/04INSIDER TRENDS : Insider at Collegium Pharmaceutical Sells Stock for Taxes Interrupting 90..
19/03COLLEGIUM PHARMACEUTICAL : Significant Insider Selling Continues at Collegium Pharmaceutic..
17/03INSIDER TRENDS : 90-Day Insider Buying Trend at Collegium Pharmaceutical Slowed with Sale ..
25/02COLLEGIUM PHARMACEUTICAL : 4Q Earnings Snapshot
25/02COLLEGIUM PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and..
25/02Collegium Pharmaceutical, Inc. Reports Earnings Results for the Full Year Ended Decembe..
25/02COLLEGIUM PHARMACEUTICAL, INC : Results of Operations and Financial Condition, Financial S..
25/02Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million
25/02Collegium Pharmaceutical, Inc. Reiterates Financial Guidance for the Full-Year 2021
15/02INSIDER TRENDS : Collegium Pharmaceutical Insider Disposes of Shares for Tax Slowing 90-Da..
15/02INSIDER TRENDS : Insider at Collegium Pharmaceutical Sells Shares for Tax Slowing 90-Day B..
15/02INSIDER TRENDS : Collegium Pharmaceutical Insider Makes Shares Sale for Tax Slowing 90-Day..
12/02COLLEGIUM PHARMACEUTICAL, INC.(NASDA : COLL) added to S&P 1000
12/02COLLEGIUM PHARMACEUTICAL, INC.(NASDA : COLL) added to S&P 600
12/02COLLEGIUM PHARMACEUTICAL, INC.(NASDA : COLL) added to S&P 600 Health Care
12/02COLLEGIUM PHARMACEUTICAL, INC.(NASDA : COLL) added to S&P Composite 1500
11/02Collegium to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and ..
09/02Monolithic Power Systems to Join S&P 500
07/01COLLEGIUM PHARMACEUTICAL : Issues 2021 Revenue Targets for Pain Medications
06/01COLLEGIUM PHARMACEUTICAL, INC : Regulation FD Disclosure, Financial Statements and Exhibit..
06/01Collegium Provides 2021 Financial Guidance
06/01Collegium Provides Revenue Guidance for the Full Year of 2021
2020COLLEGIUM PHARMACEUTICAL, INC : Change in Directors or Principal Officers, Financial State..
2020INSIDER TRENDS : 90-Day Insider Buying Trend at Collegium Pharmaceutical Interrupted with ..
2020COLLEGIUM PHARMACEUTICAL : 3Q Earnings Snapshot
2020Collegium Pharmaceutical, Inc. Reports Earnings Results for the Third Quarter Ended Sep..
2020COLLEGIUM PHARMACEUTICAL, INC : Results of Operations and Financial Condition, Financial S..
2020COLLEGIUM PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and..
2020COLLEGIUM PHARMACEUTICAL : Reports Net Income of $11.3 Million in the Third Quarter of 202..
2020Collegium Reports Net Income of $11.3 Million in the Third Quarter of 2020
2020COLLEGIUM PHARMACEUTICAL : Announces Publication of “Postmarketing Analysis of Misus..
2020Collegium Announces Publication of “Postmarketing Analysis of Misuse, Abuse, and ..
2020COLLEGIUM PHARMACEUTICAL : to Host Conference Call to Discuss Third Quarter 2020 Financial..
2020Collegium to Host Conference Call to Discuss Third Quarter 2020 Financial Results and P..
2020COLLEGIUM PHARMACEUTICAL, INC : Entry into a Material Definitive Agreement, Other Events, ..
2020COLLEGIUM PHARMACEUTICAL : Announces Settlement with Teva Resolving Xtampzaģ ER Patent Lit..
2020Collegium Announces Settlement with Teva Resolving Xtampzaģ ER Patent Litigation
2020COLLEGIUM PHARMACEUTICAL, INC : Change in Directors or Principal Officers, Other Events, F..
2020COLLEGIUM PHARMACEUTICAL : Appoints Rita Balice-Gordon to its Board of Directors
2020Collegium Appoints Rita Balice-Gordon to its Board of Directors
1  2  3  4Volgende
Volgende evenement op COLLEGIUM PHARMACEUTICAL, INC.
04/11/21